Table of Contents
Licensing
| Novartis Pays Arvinas US$150 M Upfront for Prostate Cancer Protein Degrader | Abstract pdf html |
| Lucy Haggerty |
Mergers & Acquisitions
| Genmab Acquires ADC Drug Developer ProfoundBio for US$1.8 B | Abstract pdf html |
| Lucy Haggerty |
| Vertex Buys Alpine Immune Sciences and its Kidney Disease Drug for US$4.9 B | Abstract pdf html |
| Lucy Haggerty |
This work is licensed under a Creative Commons Attribution 3.0 License.